Gavin Giovannoni is an academic neurologist at the Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London. His current research is focused on the Epstein-Barr virus as a possible cause of multiple sclerosis, MS-related neurodegeneration, biomarker discovery & validation, and MS clinical outcomes. Gavin is also an active MS blogger.
Professor of Neurology
Blizard Institute
Medicine and Dentistry
Queen Mary University of London
London, UK
Gavin Giovannoni is an academic neurologist at the Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London. His current research is focused on the Epstein-Barr virus as a possible cause of multiple sclerosis, MS-related neurodegeneration, biomarker discovery & validation, and MS clinical outcomes. Gavin is also an active MS blogger.
After achieving his medical and scientific studies in Neurology and in Neuroscience, Patrick Chauvel became an INSERM (Paris) researcher (1975). At that time, he began his work in experimental and later clinical research into the mechanisms of the epilepsies. Under the mentorship of Talairach and Bancaud at Hospital Sainte-Anne/University René Descartes, Paris, he developed SEEG (Stereo-Electro-EncephaloGraphy) as a presurgical method using intracerebral electrodes for epilepsy surgery (1975-1990). His research work has been devoted to the pathophysiology of the epileptogenic zone, emergence of seizure clinical semiology, and human cerebral cortex physiology. He has promoted the concept of epileptogenic network over the classical epileptic focus idea and opened new vistas in markers of the epileptogenic zone and semiology of focal epilepsies. Taking over from Jean Bancaud, Patrick Chauvel served as the Director of the SEEG Unit in Hospital Sainte-Anne in Paris (1986-1990), then Professor and Chairman of Neurology in Rennes (1990-1997) where he configured a new type of Epilepsy Unit including research, then Professor and Chairman of Clinical Neurophysiology and Director of the INSERM Institute of Systems Neuroscience in Marseille (1997-2014). In 2014, he relocated to the Epilepsy Center of the Cleveland Clinic in order to promote the development of presurgical investigation using SEEG in North America. He was appointed as Professor of Neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. In Brisbane, he guided developing SEEG-based epilepsy surgery and related research program.
He is currently Professor of Neurology at the University of Pittsburgh, USA, and Honorary Professor at the University of Queensland, Australia. He is developing new methods for presurgical investigation of drug-resistant epilepsies based on SEEG, and research on biomarkers of the epileptogenic zone and neural networks generating clinical semiology.
He is the author of more than 200 original articles in international journals and is a member of several international Scientific and Medical Societies. He is a Member of the Royal Academy of Medicine in Belgium.
Professor of Neurology
Epileptologist/Neuroscientist
University of Pittsburgh, USA
After achieving his medical and scientific studies in Neurology and in Neuroscience, Patrick Chauvel became an INSERM (Paris) researcher (1975). At that time, he began his work in experimental and later clinical research into the mechanisms of the epilepsies. Under the mentorship of Talairach and Bancaud at Hospital Sainte-Anne/University René Descartes, Paris, he developed SEEG (Stereo-Electro-EncephaloGraphy) as a presurgical method using intracerebral electrodes for epilepsy surgery (1975-1990). His research work has been devoted to the pathophysiology of the epileptogenic zone, emergence of seizure clinical semiology, and human cerebral cortex physiology. He has promoted the concept of epileptogenic network over the classical epileptic focus idea and opened new vistas in markers of the epileptogenic zone and semiology of focal epilepsies. Taking over from Jean Bancaud, Patrick Chauvel served as the Director of the SEEG Unit in Hospital Sainte-Anne in Paris (1986-1990), then Professor and Chairman of Neurology in Rennes (1990-1997) where he configured a new type of Epilepsy Unit including research, then Professor and Chairman of Clinical Neurophysiology and Director of the INSERM Institute of Systems Neuroscience in Marseille (1997-2014). In 2014, he relocated to the Epilepsy Center of the Cleveland Clinic in order to promote the development of presurgical investigation using SEEG in North America. He was appointed as Professor of Neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. In Brisbane, he guided developing SEEG-based epilepsy surgery and related research program.
He is currently Professor of Neurology at the University of Pittsburgh, USA, and Honorary Professor at the University of Queensland, Australia. He is developing new methods for presurgical investigation of drug-resistant epilepsies based on SEEG, and research on biomarkers of the epileptogenic zone and neural networks generating clinical semiology.
He is the author of more than 200 original articles in international journals and is a member of several international Scientific and Medical Societies. He is a Member of the Royal Academy of Medicine in Belgium.
Dr. Raed Alroughani is a consultant neurologist and the director of MS clinic at Amiri and Ibn Sina hospitals. He completed his neurology residency at the University of British Columbia and subsequently obtained the neurology certification from the Royal College of Physicians & Surgeon (Canada). He then completed a fellowship in Multiple Sclerosis at the University of British Columbia.
He is actively involved in research and he authored and co-authored more than 170 publications. Dr. Alroughani was awarded the National Prize for scientific production in the field of medical science in 2017 and the best researcher award by Amiri Hospital in 2018.
He is a founding member and the secretary general of MENACTRIMS. He is the vice chair of the Scientific Leadership Group of MS Base Foundation.
Consultant Neurologist, Director of MS Clinic
Amiri and Ibn Sina Hospital, Kuwait
Kuwait City, Kuwait
Dr. Raed Alroughani is a consultant neurologist and the director of MS clinic at Amiri and Ibn Sina hospitals. He completed his neurology residency at the University of British Columbia and subsequently obtained the neurology certification from the Royal College of Physicians & Surgeon (Canada). He then completed a fellowship in Multiple Sclerosis at the University of British Columbia.
He is actively involved in research and he authored and co-authored more than 170 publications. Dr. Alroughani was awarded the National Prize for scientific production in the field of medical science in 2017 and the best researcher award by Amiri Hospital in 2018.
He is a founding member and the secretary general of MENACTRIMS. He is the vice chair of the Scientific Leadership Group of MS Base Foundation.
Dr. Mohammed Alhatou has a special interest in headache, neuro-immunology and neuromuscular diseases. He chaired the Department of Neurology at the Regional Medical Center of Orangeburg and Calhoun Counties from 2002 to 2015 and recently joined Hamad Medical Corporation where he is a Senior Consultant, Director of Neuromuscular Division at HMC and Head of Neurology at Alkhor Hospital.
Dr. Alhatou is American Board-Certified in Neurology, Clinical Neurophysiology, Electromyography, Neuromuscular Disorders, Neuroimaging and Sleep Medicine. He completed his Residency in Neurology at the University of Virginia and his Fellowship in Neuromuscular Disease and Electromyography at Emory University.
He is a primary investigator in multiple drug studies in neuropathy, dementia, stroke and epilepsy. He is the Chair of Qatar Board of Neurology and Qatar representative to Arab Board of Neurology.
Senior Consultant
Director of Neuromuscular Division
Hamad Medical Corporation/Head of Neurology
Alkhor Hospital, Al Dhakira, Qatar
Dr. Mohammed Alhatou has a special interest in headache, neuro-immunology and neuromuscular diseases. He chaired the Department of Neurology at the Regional Medical Center of Orangeburg and Calhoun Counties from 2002 to 2015 and recently joined Hamad Medical Corporation where he is a Senior Consultant, Director of Neuromuscular Division at HMC and Head of Neurology at Alkhor Hospital.
Dr. Alhatou is American Board-Certified in Neurology, Clinical Neurophysiology, Electromyography, Neuromuscular Disorders, Neuroimaging and Sleep Medicine. He completed his Residency in Neurology at the University of Virginia and his Fellowship in Neuromuscular Disease and Electromyography at Emory University.
He is a primary investigator in multiple drug studies in neuropathy, dementia, stroke and epilepsy. He is the Chair of Qatar Board of Neurology and Qatar representative to Arab Board of Neurology.
Dr Siti Aisyah Yaacob graduated in 2004 from the University of Glasgow, UK. After completing her specialty training, she is now working as a Consultant Clinical Neurophysiologist at Institute of Neuroscience, Queen Elizabeth University Hospital, Glasgow. She provides diagnostic evaluation for epilepsy and neuromuscular conditions. She has experience in interpreting EEG and EEG monitoring which includes Video Telemetry and Ambulatory EEG. She has prior neurology experience in epilepsy, neuromuscular disorders, and paediatric neurology. She has special interests in intraoperative neuromonitoring in adult and paediatric. She provides neuromonitoring for the Scottish National Service for Selective Dorsal Rhizotomy and Deep Brain Stimulation.
Consultant Clinical Neurophysiologist
Queen Elizabeth University Hospital,
Glasgow, UK
Dr Siti Aisyah Yaacob graduated in 2004 from the University of Glasgow, UK. After completing her specialty training, she is now working as a Consultant Clinical Neurophysiologist at Institute of Neuroscience, Queen Elizabeth University Hospital, Glasgow. She provides diagnostic evaluation for epilepsy and neuromuscular conditions. She has experience in interpreting EEG and EEG monitoring which includes Video Telemetry and Ambulatory EEG. She has prior neurology experience in epilepsy, neuromuscular disorders, and paediatric neurology. She has special interests in intraoperative neuromonitoring in adult and paediatric. She provides neuromonitoring for the Scottish National Service for Selective Dorsal Rhizotomy and Deep Brain Stimulation.
Dr. Omer Suhaib is a triple board-certified Neurologist. These include certifications in general neurology and neuromuscular medicine through the American Board of Psychiatry and Neurology. He is also a diplomate of the American Board of Neuromuscular and Electrodiagnostic Medicine. He completed his residency in neurology at the University of Oklahoma College of Medicine where he received the “Resident of the Year” award. He did further fellowship training in Neuromuscular Medicine at the Cleveland Clinic Foundation in Cleveland, Ohio where he had specialized training in EMG, supplementing the ability to recognize patterns for neuromuscular disorders. He has been practicing at Integris Baptist Medical Center in Oklahoma City, USA for the past 5 years. Additionally, he has also worked at Tawam Hospital, Abu Dhabi UAE as a neuromuscular consultant and continues to practice part time in the UAE. He is also an international speaker for the gulf region to help educate physicians about the drug Efgartigimod for Myasthenia Gravis
Consultant Neurologist
Integris Baptist Medical Center
Oklahoma, US
Dr. Omer Suhaib is a triple board-certified Neurologist. These include certifications in general neurology and neuromuscular medicine through the American Board of Psychiatry and Neurology. He is also a diplomate of the American Board of Neuromuscular and Electrodiagnostic Medicine. He completed his residency in neurology at the University of Oklahoma College of Medicine where he received the “Resident of the Year” award. He did further fellowship training in Neuromuscular Medicine at the Cleveland Clinic Foundation in Cleveland, Ohio where he had specialized training in EMG, supplementing the ability to recognize patterns for neuromuscular disorders. He has been practicing at Integris Baptist Medical Center in Oklahoma City, USA for the past 5 years. Additionally, he has also worked at Tawam Hospital, Abu Dhabi UAE as a neuromuscular consultant and continues to practice part time in the UAE. He is also an international speaker for the gulf region to help educate physicians about the drug Efgartigimod for Myasthenia Gravis
Ms. Angela Welch have been a qualified Nurse for 20 years, qualifying in September 2022.
She began her career in QUEH taking up a rotational post incorporating Neurosurgery, Neurology, ENT, Maxillofacial and Neurology which gave her great experience and insight to clinical conditions within each speciality.
She spent 6 years in the Institute for Neurological Sciences Critical Care Unit working in both HDU and ITU.
Following this she went on to spend 13 years working on Stroke Research and Acute Stroke Care where she laterally became a Charge Nurse in the Hyper Acute Stroke Unit.
The last year has seen her take up a new post as a Trainee Advanced Nurse Practitioner in Neurosurgery/Oral-Maxillo Facial Surgery. During this time she have worked full time and also studying part time for a Masters degree.
Trainee ANP Neurosurgery / OMFS
Queen Elizabeth University Hospital
Glasgow, United Kingdom
Ms. Angela Welch have been a qualified Nurse for 20 years, qualifying in September 2022.
She began her career in QUEH taking up a rotational post incorporating Neurosurgery, Neurology, ENT, Maxillofacial and Neurology which gave her great experience and insight to clinical conditions within each speciality.
She spent 6 years in the Institute for Neurological Sciences Critical Care Unit working in both HDU and ITU.
Following this she went on to spend 13 years working on Stroke Research and Acute Stroke Care where she laterally became a Charge Nurse in the Hyper Acute Stroke Unit.
The last year has seen her take up a new post as a Trainee Advanced Nurse Practitioner in Neurosurgery/Oral-Maxillo Facial Surgery. During this time she have worked full time and also studying part time for a Masters degree.
King faisal Specialist Hospital & Research Center
Riyadh Neuroscience Department
Neurology Section
Riyadh, Saudi Arabia
King Faisal Specialist Hospital & Research Center
Riyadh Neuroscience Department
Neurology Section
Riyadh, Saudi Arabia
King faisal Specialist Hospital & Research Center
Riyadh Neuroscience Department
Neurology Section
Riyadh, Saudi Arabia
Prof. Messoud Ashina is Professor of Neurology in the Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Professor Ashina received his Doctor of Medicine Degree at the Azerbaijan Medical University. He completed his residency in neurology at the University of Copenhagen. Dr. Ashina received his PhD and DMSc degrees at the University of Copenhagen.
He is Director of the Human Migraine Research Unit at the Danish Headache Center and Department of Neurology, Rigshospitalet Glostrup.
Professor Ashina has been actively involved in headache research since 1995. His research interests include experimental migraine and cluster headache models, neuroimaging, novel antimigraine drug targets, mechanism of migraine and action of antimigraine medications. He has authored over 400 papers, abstracts and book chapters on the topic of headache, including migraine and cluster headache.
Messoud Ashina serves as associate editor of Cephalalgia, associate editor of Headache and associate editor of The Journal of Headache and Pain. Professor Ashina is Past-President of the International Headache Society.
Professor of Neurology
Faculty of Health and Medical Sciences
University of Copenhagen
Denmark
Prof. Messoud Ashina is Professor of Neurology in the Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Professor Ashina received his Doctor of Medicine Degree at the Azerbaijan Medical University. He completed his residency in neurology at the University of Copenhagen. Dr. Ashina received his PhD and DMSc degrees at the University of Copenhagen.
He is Director of the Human Migraine Research Unit at the Danish Headache Center and Department of Neurology, Rigshospitalet Glostrup.
Professor Ashina has been actively involved in headache research since 1995. His research interests include experimental migraine and cluster headache models, neuroimaging, novel antimigraine drug targets, mechanism of migraine and action of antimigraine medications. He has authored over 400 papers, abstracts and book chapters on the topic of headache, including migraine and cluster headache.
Messoud Ashina serves as associate editor of Cephalalgia, associate editor of Headache and associate editor of The Journal of Headache and Pain. Professor Ashina is Past-President of the International Headache Society.
Prof. Alan M. Rapoport, M.D. is a Clinical Professor of Neurology at The David Geffen School of Medicine at UCLA, Los Angeles, California and is a Past-President of the International Headache Society, as well as the founder and Director-Emeritus of The New England Center for Headache, in Stamford, Connecticut. He has a private practice in Headache and General Neurology in Santa Monica, CA at the California Medical Clinic for Headache. Board-certified in Neurology and Headache Medicine, he has co-authored more then 300 articles, chapters and posters on headache and other neurological conditions as well as 9 books for physicians and patients on headache. He has lectured around the country and internationally to general physicians, neurologists and headache specialists on all aspects of headache pathophysiology, diagnosis and treatment and has appeared many times on national radio and television programs, such as Today, Good Morning America, CBS This Morning and 20/20.
He is an editor of Headache, CNS Drugs and Editor in Chief of Neurology Reviews, and he reviews for many peer-reviewed journals such as Cephalalgia, Neurology, New England Journal of Medicine and Headache.
Dr. Rapoport has served on the Board of Directors of the American Headache Society (AHS) and is the immediate past President of the Fairfield County Neurological Society, the Founding President of the Headache Cooperative of New England (HCNE), the founding Director of the Headache Cooperative of the Pacific (HCOP) and until recently was the Chairman of the Education and Membership Committee of the International Headache Society (IHS). He was elected to the position of President President of the International Headache Society in April 2013 and is now a Past- President. He is the co-founder of an IT non-profit company named ProMyHealth which offers on line consultations to headache patients and produces a written consultation for them to take to their physician.He is CEO of BonTriage which is an IT Health Care company that takes on line expert histories for headache and also helps screen potential patients for clinical trials.
Dr. Rapoport has testified many times in court for both defense and plaintiff and often reviews medical records and consults with attorneys and their staff. His expertise is in headache but he has been involved in personal injury and several patent cases, often related to neurological programs, headache and pain.
Dr. Rapoport has been an expert in 3 large patent infringement cases.
Professor of Neurology
The David Geffen School of Medicine at UCLA
Los Angeles, US
Prof. Alan M. Rapoport, M.D. is a Clinical Professor of Neurology at The David Geffen School of Medicine at UCLA, Los Angeles, California and is a Past-President of the International Headache Society, as well as the founder and Director-Emeritus of The New England Center for Headache, in Stamford, Connecticut. He has a private practice in Headache and General Neurology in Santa Monica, CA at the California Medical Clinic for Headache. Board-certified in Neurology and Headache Medicine, he has co-authored more then 300 articles, chapters and posters on headache and other neurological conditions as well as 9 books for physicians and patients on headache. He has lectured around the country and internationally to general physicians, neurologists and headache specialists on all aspects of headache pathophysiology, diagnosis and treatment and has appeared many times on national radio and television programs, such as Today, Good Morning America, CBS This Morning and 20/20.
He is an editor of Headache, CNS Drugs and Editor in Chief of Neurology Reviews, and he reviews for many peer-reviewed journals such as Cephalalgia, Neurology, New England Journal of Medicine and Headache.
Dr. Rapoport has served on the Board of Directors of the American Headache Society (AHS) and is the immediate past President of the Fairfield County Neurological Society, the Founding President of the Headache Cooperative of New England (HCNE), the founding Director of the Headache Cooperative of the Pacific (HCOP) and until recently was the Chairman of the Education and Membership Committee of the International Headache Society (IHS). He was elected to the position of President President of the International Headache Society in April 2013 and is now a Past- President. He is the co-founder of an IT non-profit company named ProMyHealth which offers on line consultations to headache patients and produces a written consultation for them to take to their physician.He is CEO of BonTriage which is an IT Health Care company that takes on line expert histories for headache and also helps screen potential patients for clinical trials.
Dr. Rapoport has testified many times in court for both defense and plaintiff and often reviews medical records and consults with attorneys and their staff. His expertise is in headache but he has been involved in personal injury and several patent cases, often related to neurological programs, headache and pain.
Dr. Rapoport has been an expert in 3 large patent infringement cases.
Section Head & Consultant of Neurology
International Medical Center
Jeddah, Saudi Arabia
Section Head & Consultant of Neurology
International Medical Center
Jeddah, Saudi Arabia
Section Head & Consultant of Neurology
International Medical Center
Jeddah, Saudi Arabia
Dawn C. Buse PhD is a Clinical Professor of Neurology at Albert Einstein College of Medicine in New York City, an Assistant Professor in the Clinical Health Psychology Doctoral Program of Ferkauf Graduate School of Psychology and was the Director of Behavioral Medicine at the Montefiore Headache Center from 2006-2018. She is a licensed psychologist and is a Board Member and a fellow of the American Headache Society (AHS).
Dr. Buse conducts research on migraine, pain and stress among other conditions and is a co-investigator on the American Migraine Prevalence and Prevention (AMPP) Study, the Chronic Migraine Epidemiology and Outcomes (CAMEO) Study, the International Burden of Migraine (IBMS) Study, the Migraine, Symptoms and Treatment in America (MAST) Study and the Migraine Signature Study. She has coauthored more than 100 manuscripts in peer reviewed scientific journals, 54 review articles and book chapters and more than 400 scientific abstracts. Her manuscripts have won the American Headache Society’s “Wolff Award” twice (2008 and 2018), the Italian Society for the Study of Headache’s “Enrico Greppi Award” twice (2009 and 2017), the British Medical Journal’s “Patient’s Choice Award”, and the 2015 “Headache Reader’s Choice” Award. In 2009 she won the National Headache Foundation, “Partners in Excellence” Award and in 2016 she won the American Headache Society “Seymour Solomon” Award.
After earning a master’s degree and a doctorate in psychology from the University of Utah, Dr. Buse completed an internship in medical psychology in the Boston VA Medical System and Harvard Medical School and 3 years of postdoctoral fellowships in adult and pediatric headache and pain management at Spaulding Rehabilitation Hospital, Massachusetts General Hospital, Children’s Hospital, Boston, and Harvard Medical School.
Dr. Buse mentors graduate students in the Ferkauf Doctoral Health Psychology program. Dr. Buse is the psychological and behavioral section editor for Current Pain and Headache Reports and she serves on the advisory board of the Journal of Headache and Pain, Pain Management News, and Pain Pathways Magazine. She is on the American Headache Society Board of Directors and Electronic Media Committee, and the American Academy of Neurology Digital Strategy Subcommittee.
Clinical Professor of Neurology
Albert Einstein College of Medicine
New York
Dawn C. Buse PhD is a Clinical Professor of Neurology at Albert Einstein College of Medicine in New York City, an Assistant Professor in the Clinical Health Psychology Doctoral Program of Ferkauf Graduate School of Psychology and was the Director of Behavioral Medicine at the Montefiore Headache Center from 2006-2018. She is a licensed psychologist and is a Board Member and a fellow of the American Headache Society (AHS).
Dr. Buse conducts research on migraine, pain and stress among other conditions and is a co-investigator on the American Migraine Prevalence and Prevention (AMPP) Study, the Chronic Migraine Epidemiology and Outcomes (CAMEO) Study, the International Burden of Migraine (IBMS) Study, the Migraine, Symptoms and Treatment in America (MAST) Study and the Migraine Signature Study. She has coauthored more than 100 manuscripts in peer reviewed scientific journals, 54 review articles and book chapters and more than 400 scientific abstracts. Her manuscripts have won the American Headache Society’s “Wolff Award” twice (2008 and 2018), the Italian Society for the Study of Headache’s “Enrico Greppi Award” twice (2009 and 2017), the British Medical Journal’s “Patient’s Choice Award”, and the 2015 “Headache Reader’s Choice” Award. In 2009 she won the National Headache Foundation, “Partners in Excellence” Award and in 2016 she won the American Headache Society “Seymour Solomon” Award.
After earning a master’s degree and a doctorate in psychology from the University of Utah, Dr. Buse completed an internship in medical psychology in the Boston VA Medical System and Harvard Medical School and 3 years of postdoctoral fellowships in adult and pediatric headache and pain management at Spaulding Rehabilitation Hospital, Massachusetts General Hospital, Children’s Hospital, Boston, and Harvard Medical School.
Dr. Buse mentors graduate students in the Ferkauf Doctoral Health Psychology program. Dr. Buse is the psychological and behavioral section editor for Current Pain and Headache Reports and she serves on the advisory board of the Journal of Headache and Pain, Pain Management News, and Pain Pathways Magazine. She is on the American Headache Society Board of Directors and Electronic Media Committee, and the American Academy of Neurology Digital Strategy Subcommittee.
Dr. Jaber Al Khaboori is a Senior consultant neurologist in Khoula Hospital, Muscat, Oman. He graduated from Sultan Qaboos University Hospital Medical School in 1994.
He was a distinguished student as he got The Dean award of achievement. His medical training was in royal hospital and got the Award of Oman medical specialty board for the best resident.
He passed his MRCP Diploma in 1997 from Glasgow. He has neurology training was in London from 1998 to 2003 as a specialist visiting registrar. His main interest is multiple sclerosis and vascular pathology. His research involved in oral treatment for multiple sclerosis and Cannabis use in MS.
He has published few papers including MS in Oman. He is running the MS clinic.
Senior Consultant Neurologist, Head of Neurology
Royal Hospital
Muscat, Oman
Dr. Jaber Al Khaboori is a Senior consultant neurologist in Khoula Hospital, Muscat, Oman. He graduated from Sultan Qaboos University Hospital Medical School in 1994.
He was a distinguished student as he got The Dean award of achievement. His medical training was in royal hospital and got the Award of Oman medical specialty board for the best resident.
He passed his MRCP Diploma in 1997 from Glasgow. He has neurology training was in London from 1998 to 2003 as a specialist visiting registrar. His main interest is multiple sclerosis and vascular pathology. His research involved in oral treatment for multiple sclerosis and Cannabis use in MS.
He has published few papers including MS in Oman. He is running the MS clinic.
Dr. Abdulla Al Kuwaiti graduated from UAE university medical college and health science in 2009, and was thrilled about neuroscience. In 2010 he joined McGill University in Montreal, Canada, and had extensive work experience with pioneers in neurology and epilepsy. Dr. Abdulla has successfully completed his neurology residency, and followed by an Epilepsy fellowship, with a special interest in Magnetoencephalography (MEG) technology in Montreal Neurological institute and hospital, and other affiliated hospitals. Currently, he is a consultant Neurologist at Tawam hospital and in his first year after returning from Canada, he has upgraded the EEG service to a fully digital network. First in Tawam Hospital to use Ictal and interictal SPECT for frontal lobe seizure patients.
Dr. Abdulla’s clinical interest equals his interest in educating and training the new generation of physicians, being involved in final year medical education teaching when he was in Canada and currently in UAE. Dr. Abdulla has presented multiple talks at conferences and annual meetings, on topics including; headache and epilepsy, super refractory status epilepticus, and neurological complications of bariatric surgery. In addition, he has run an EEG (electroencephalogram) workshop at the first Abu Dhabi brain conference Sept 2021. Dr. Abdulla was involved in multiple research projects in Canada and UAE, and published several papers and presented posters at neurological conferences.
Graduated from UAE university college of medicine and health sciences in 2008, followed by Neurology residency, Epilepsy and EEG fellowship in Montreal Neurological institute and hospital. Joined Tawam as consultant neurologist in 2019.
Consultant Neurologist & Epileptologist
Tawam Hospital
Abu Dhabi, UAE
Dr. Abdulla Al Kuwaiti graduated from UAE university medical college and health science in 2009, and was thrilled about neuroscience. In 2010 he joined McGill University in Montreal, Canada, and had extensive work experience with pioneers in neurology and epilepsy. Dr. Abdulla has successfully completed his neurology residency, and followed by an Epilepsy fellowship, with a special interest in Magnetoencephalography (MEG) technology in Montreal Neurological institute and hospital, and other affiliated hospitals. Currently, he is a consultant Neurologist at Tawam hospital and in his first year after returning from Canada, he has upgraded the EEG service to a fully digital network. First in Tawam Hospital to use Ictal and interictal SPECT for frontal lobe seizure patients.
Dr. Abdulla’s clinical interest equals his interest in educating and training the new generation of physicians, being involved in final year medical education teaching when he was in Canada and currently in UAE. Dr. Abdulla has presented multiple talks at conferences and annual meetings, on topics including; headache and epilepsy, super refractory status epilepticus, and neurological complications of bariatric surgery. In addition, he has run an EEG (electroencephalogram) workshop at the first Abu Dhabi brain conference Sept 2021. Dr. Abdulla was involved in multiple research projects in Canada and UAE, and published several papers and presented posters at neurological conferences.
Graduated from UAE university college of medicine and health sciences in 2008, followed by Neurology residency, Epilepsy and EEG fellowship in Montreal Neurological institute and hospital. Joined Tawam as consultant neurologist in 2019.
Dr. Abubaker Almadani completed his undergraduate certificate in 1997 from the University of Gothenburg, Sweden. In Gothernburg University, he was involved in teaching and contributed in research study with Dr. Anders Hamberger in neuroprotective agents in acute stroke. Then, he completed his Canadian Royal College in Neurology (FRCPC) in 2009.
Dr. Madani had his residency at the University of Toronto which is ranked number 1 in Canada by Royal College of Canada, and ranked number 4 in the whole North America by American Academy of Neurology. He was personally involved in regional stroke program and he was involved in at least 500 stroke cases and 80 TPA cases. In his residency he also did one whole elective year which involves EEG, research, pathology and nerve conduction studies. By finishing the residency, he was able to manage neurological cases as general neurological cases as general neurologist in 2007. He has his fellowship in neuromuscular subspecialty from 2007 to 2009.
Consultant & Head of Neurology Department
Rashid Hospital
Dubai, UAE
Dr. Abubaker Almadani completed his undergraduate certificate in 1997 from the University of Gothenburg, Sweden. In Gothernburg University, he was involved in teaching and contributed in research study with Dr. Anders Hamberger in neuroprotective agents in acute stroke. Then, he completed his Canadian Royal College in Neurology (FRCPC) in 2009.
Dr. Madani had his residency at the University of Toronto which is ranked number 1 in Canada by Royal College of Canada, and ranked number 4 in the whole North America by American Academy of Neurology. He was personally involved in regional stroke program and he was involved in at least 500 stroke cases and 80 TPA cases. In his residency he also did one whole elective year which involves EEG, research, pathology and nerve conduction studies. By finishing the residency, he was able to manage neurological cases as general neurological cases as general neurologist in 2007. He has his fellowship in neuromuscular subspecialty from 2007 to 2009.
Dr. Bassem Yammout is currently Professor of Neurology at the American University of Beirut Medical Center and director of the Neurology Institute at Harley Street Medical Center in Abu Dhabi. He graduated from medical school at AUB in 1984, received his training in neurology at the University of Cincinnati-Ohio in the USA, and followed by a fellowship at the Montreal Neurological Institute-McGill University in Canada. He received his American Board in Neurology and joined the faculty at the American University of Beirut in 1988. He is currently head of clinical research at the Multiple Sclerosis Center, president of MENACTRIMS (Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis), member of the MSIF (Multiple Sclerosis International Federation) Scientific Advisory Board, and fellow of the American Academy of Neurology.
Dr. Yammout is one of the leading experts on multiple sclerosis in the Middle East with recent research on epidemiology of the disease in the region, quality of life of patients in the Middle East. In addition, he is currently the principal investigator on several ongoing international multiple sclerosis research trials. Dr. Yammout has authored many research and review papers and is currently Chief Editor of the MS newsletter “MS today”, and on the editorial board of “Multiple Sclerosis and Related Disorders”, “Journal of Multiple Sclerosis” and “Pediatric Neurology”.
Professor of Neurology,
American University of Beirut, Lebanon
Director, Neurology Institute & Head, MS Center,
Harley Street Medical Center
Abu Dhabi, UAE
Dr. Bassem Yammout is currently Professor of Neurology at the American University of Beirut Medical Center and director of the Neurology Institute at Harley Street Medical Center in Abu Dhabi. He graduated from medical school at AUB in 1984, received his training in neurology at the University of Cincinnati-Ohio in the USA, and followed by a fellowship at the Montreal Neurological Institute-McGill University in Canada. He received his American Board in Neurology and joined the faculty at the American University of Beirut in 1988. He is currently head of clinical research at the Multiple Sclerosis Center, president of MENACTRIMS (Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis), member of the MSIF (Multiple Sclerosis International Federation) Scientific Advisory Board, and fellow of the American Academy of Neurology.
Dr. Yammout is one of the leading experts on multiple sclerosis in the Middle East with recent research on epidemiology of the disease in the region, quality of life of patients in the Middle East. In addition, he is currently the principal investigator on several ongoing international multiple sclerosis research trials. Dr. Yammout has authored many research and review papers and is currently Chief Editor of the MS newsletter “MS today”, and on the editorial board of “Multiple Sclerosis and Related Disorders”, “Journal of Multiple Sclerosis” and “Pediatric Neurology”.
Dr. Deeb Kayed is an American Board Certified Neurologist (1997) and Clinical Neurophysiologist (1999) with a particular interest in headaches.
Dr. Kayed graduated magna cum laude from the University of Evansville with a Bachelor of Science degree in Biology in 1986. He then graduated from St George’s University School of Medicine in 1990.
He completed his residency training in Adult Neurology at Temple University Hospital, Philadelphia, PA, USA in 1996 where he also served as Chief Resident. He next completed a Fellowship in Clinical Neurophysiology at Hahnemann University Hospital in Philadelphia in 1997 followed by a Fellowship in Advanced Clinical Neurology – Child Neurology at Jefferson University Hospital, Philadelphia in 1998.
Dr Kayed relocated to The UAE in 2000 and served as a Consultant Neurologist at Tawam Hospital in Al Ain where he was also Head of the Division of Neurology. At the Faculty of Medicine & Health Sciences, UAE University, Dr. Kayed served as Adjunct Clinical Assistant Professor.
Dr.Kayed relocated to Dubai in 2005 where he has been working in private practice. He is an Assistant Professor at the MBRU School of Medicine. His practice is currently located at The Integrated Rheumatology & Arthritis Centre in Dubai Health Care City. He is an Independent Doctor, Consultant Neurologist, at The Mediclinic City Hospital Dubai in Dubai Health Care City. Dr Kayed’s primary interest is in the management of patients with headaches, in particular migraine.
Consultant Neurologist
Assistant Professor
MBRU, Private Practice
Dubai, UAE
Dr. Deeb Kayed is an American Board Certified Neurologist (1997) and Clinical Neurophysiologist (1999) with a particular interest in headaches.
Dr. Kayed graduated magna cum laude from the University of Evansville with a Bachelor of Science degree in Biology in 1986. He then graduated from St George’s University School of Medicine in 1990.
He completed his residency training in Adult Neurology at Temple University Hospital, Philadelphia, PA, USA in 1996 where he also served as Chief Resident. He next completed a Fellowship in Clinical Neurophysiology at Hahnemann University Hospital in Philadelphia in 1997 followed by a Fellowship in Advanced Clinical Neurology – Child Neurology at Jefferson University Hospital, Philadelphia in 1998.
Dr Kayed relocated to The UAE in 2000 and served as a Consultant Neurologist at Tawam Hospital in Al Ain where he was also Head of the Division of Neurology. At the Faculty of Medicine & Health Sciences, UAE University, Dr. Kayed served as Adjunct Clinical Assistant Professor.
Dr.Kayed relocated to Dubai in 2005 where he has been working in private practice. He is an Assistant Professor at the MBRU School of Medicine. His practice is currently located at The Integrated Rheumatology & Arthritis Centre in Dubai Health Care City. He is an Independent Doctor, Consultant Neurologist, at The Mediclinic City Hospital Dubai in Dubai Health Care City. Dr Kayed’s primary interest is in the management of patients with headaches, in particular migraine.
Assistant Professor
Physiotherapy Department
Fatima College of Health Sciences
Abu Dhabi, UAE
Assistant Professor
Physiotherapy Department
Fatima College of Health Sciences
Abu Dhabi, UAE
Assistant Professor
Physiotherapy Department
Fatima College of Health Sciences
Abu Dhabi, UAE
Prof. Jihad Inshasi is a Consultant Neurologist at Rashid Hospital, Dubai Health Authority (DHA), and a Professor of Neurology at Dubai Medical College (DMC/DHA). He developed and currently directs the Multiple Sclerosis Clinic and established the Dystonia Clinic at Rashid Hospital/DHA.
Prof. Inshasi is the Head of the Scientific Committee and a Founding and Board Member of the Emirates Neurology Society (EMINS/EMA). With the EMINS Board Members, he has organized numerous neurology meetings, particularly in the field of multiple sclerosis. He is founding and executive board member of the MENACTRIMS. He is also a Founding Member, and ex-President of the Emirates League against Epilepsy (ILAE).
Prof. Inshasi has authored and co-authored many scientific papers published in peer-reviewed journals. He has participated as principle and leading investigator in phase 2, 3 & 4 drug trials and has conducted an array of research projects in the field of multiple sclerosis.
Prof. Inshasi is a member of several local, regional and international associations, societies and advisory boards committees. He is a Fellow of the American Academy of Neurology (FAAN) and a Fellow of the European Academy of neurology (FEAN).
Consultant Neurologist
Professor of Neurology
Rashid Hospital
Dubai, UAE
Prof. Jihad Inshasi is a Consultant Neurologist at Rashid Hospital, Dubai Health Authority (DHA), and a Professor of Neurology at Dubai Medical College (DMC/DHA). He developed and currently directs the Multiple Sclerosis Clinic and established the Dystonia Clinic at Rashid Hospital/DHA.
Prof. Inshasi is the Head of the Scientific Committee and a Founding and Board Member of the Emirates Neurology Society (EMINS/EMA). With the EMINS Board Members, he has organized numerous neurology meetings, particularly in the field of multiple sclerosis. He is founding and executive board member of the MENACTRIMS. He is also a Founding Member, and ex-President of the Emirates League against Epilepsy (ILAE).
Prof. Inshasi has authored and co-authored many scientific papers published in peer-reviewed journals. He has participated as principle and leading investigator in phase 2, 3 & 4 drug trials and has conducted an array of research projects in the field of multiple sclerosis.
Prof. Inshasi is a member of several local, regional and international associations, societies and advisory boards committees. He is a Fellow of the American Academy of Neurology (FAAN) and a Fellow of the European Academy of neurology (FEAN).
Dr. Maria Junaidi is a Stroke Neurologist practicing in Rashid Hospital, Dubai for the past eight years. She is a graduate of the Aga Khan University in Karachi, Pakistan and completed her post graduate training from the same institute. She holds a fellowship in vascular neurology and is one of the founding members for MENA stroke organization. She has over the past years carried out many academic and training activities related to stroke across the region. She has recently been elected to the Board of Directors of the World Stroke Organization and wishes to continue her work to improve stroke care in the region under this wider umbrella. She is also an avid researcher and has a number of publications in international peer reviewed journals.
Stroke Neurologist, Rashid Hospital
Member Board of Directors, World Stroke Organization
Executive member, MENA Stroke Organization
Dubai, UAE
Dr. Maria Junaidi is a Stroke Neurologist practicing in Rashid Hospital, Dubai for the past eight years. She is a graduate of the Aga Khan University in Karachi, Pakistan and completed her post graduate training from the same institute. She holds a fellowship in vascular neurology and is one of the founding members for MENA stroke organization. She has over the past years carried out many academic and training activities related to stroke across the region. She has recently been elected to the Board of Directors of the World Stroke Organization and wishes to continue her work to improve stroke care in the region under this wider umbrella. She is also an avid researcher and has a number of publications in international peer reviewed journals.
Miklós Szólics MD, PhD, EDiNR serves as a Consultant Neurologist at Tawam Hospital and holds the position of adjunct Full Professor in the Department of Medicine at the College of Medicine and Health Sciences, UAEU. He is certified in Neurology, Radiology, and Neuroradiology by the Hungarian board.
He has been serving Tawam Hospital and the Al Ain community as a Consultant Neurologist for over 22 years, with more than 20 years of previous clinical experience in Hungary and Ukraine.
Formerly held the role of chief of the Neurology Division, he has been pivotal in initiating and overseeing the Multiple Sclerosis clinic at Tawam Hospital since 2007, continuing to direct its operations to the present day.
His professional interests: Neuro-Vascular and MS /Autoimmune Neurology; Diagnostic Neuroimaging and Neuro-Electrophysiology.
Adjunct Full Professor
Department of Medicine
CHMS, UAEU
Consultant Neurologist
Division of Neurology
Department of Medicine
Tawam Hospital, Al Ain, UAE
Miklós Szólics MD, PhD, EDiNR serves as a Consultant Neurologist at Tawam Hospital and holds the position of adjunct Full Professor in the Department of Medicine at the College of Medicine and Health Sciences, UAEU. He is certified in Neurology, Radiology, and Neuroradiology by the Hungarian board.
He has been serving Tawam Hospital and the Al Ain community as a Consultant Neurologist for over 22 years, with more than 20 years of previous clinical experience in Hungary and Ukraine.
Formerly held the role of chief of the Neurology Division, he has been pivotal in initiating and overseeing the Multiple Sclerosis clinic at Tawam Hospital since 2007, continuing to direct its operations to the present day.
His professional interests: Neuro-Vascular and MS /Autoimmune Neurology; Diagnostic Neuroimaging and Neuro-Electrophysiology.
Dr. Mohammed Alkuwaiti is an Assistant Professor and Consultant Vascular Neurologist at the Department of Internal medicine in the College of Medicine and Health Sciences at United Arab Emirates University. His clinical practice is based at the Tawam hospital, the regional stroke center of Alain city in UAE. Following completion of his medical school training at UAE University he travelled to Montreal, Canada where he completed Adult Neurology residency training at McGill University (2016). He later also completed Acute stroke clinical training (2017) and Stroke-Net Fellowships (2018) at the University of Minnesota, in Minneapolis, United States. Dr. Alkuwaiti is an active member in local stroke committees, including the Department of Health stroke committee and at SEHA Stroke Task force committee. He Chairs the National Institute of Health Subspeciality (Emirates board) Neurology Committee. He is interested in secondary prevention and acute Stroke research. He is currently working on Stroke related projects in collaboration with UAE University and Sheikh Khalifa Stroke Institute.
Assistant Professor
United Arab Emirates University
College of Medicine and Health Science
Department of Internal Medicine
Consultant Neurologist
Tawam Hospital, Al Ain, UAE
Dr. Mohammed Alkuwaiti is an Assistant Professor and Consultant Vascular Neurologist at the Department of Internal medicine in the College of Medicine and Health Sciences at United Arab Emirates University. His clinical practice is based at the Tawam hospital, the regional stroke center of Alain city in UAE. Following completion of his medical school training at UAE University he travelled to Montreal, Canada where he completed Adult Neurology residency training at McGill University (2016). He later also completed Acute stroke clinical training (2017) and Stroke-Net Fellowships (2018) at the University of Minnesota, in Minneapolis, United States. Dr. Alkuwaiti is an active member in local stroke committees, including the Department of Health stroke committee and at SEHA Stroke Task force committee. He Chairs the National Institute of Health Subspeciality (Emirates board) Neurology Committee. He is interested in secondary prevention and acute Stroke research. He is currently working on Stroke related projects in collaboration with UAE University and Sheikh Khalifa Stroke Institute.
Muhammed Al-Jarrah is a professor of physiotherapy graduated from the University of Kansas Medical Center. USA in 2006. Prof. Al-Jarrah joined FCHS in 2012 to establish the Physiotherapy Department and he was the Dean of the Faculty of Applied Medical Sciences at Jordan University of Science and Technology. Over the last ten years Prof. Al-Jarrah published more than 55 papers in well recognized journals. His research interests have focused on rehabilitation of Parkinson’s disease, stroke, and cerebral palsy. He is currently leading international grants in The Middle East to develop new approaches in the fields of cerebral palsy and stroke rehabilitation.
Head of Physiotherapy Department
Fatima College of Health Sciences
Abu Dhabi, UAE
Muhammed Al-Jarrah is a professor of physiotherapy graduated from the University of Kansas Medical Center. USA in 2006. Prof. Al-Jarrah joined FCHS in 2012 to establish the Physiotherapy Department and he was the Dean of the Faculty of Applied Medical Sciences at Jordan University of Science and Technology. Over the last ten years Prof. Al-Jarrah published more than 55 papers in well recognized journals. His research interests have focused on rehabilitation of Parkinson’s disease, stroke, and cerebral palsy. He is currently leading international grants in The Middle East to develop new approaches in the fields of cerebral palsy and stroke rehabilitation.
Prof. Naji Riachi recently joined Sheikh Shakhbout Medical City as Consultant Neurologist and Khalifa University College of Medicine as Clerkship Director of Neurology and Assistant Dean for Clinical Affairs. Dr. Riachi was previously Tenured Full Professor and Chair of Department of Neurology at the Lebanese American University and Assistant Dean for Clinical Research at LAU School of Medicine in Beirut, Lebanon.
After a 4 years Post-Doctoral Research Fellowship at Case Western Reserve University in Cleveland, Ohio, he completed his Residency in Neurology at the University Hospitals of Cleveland, then a two-year Fellowship in Epilepsy and Clinical Neurophysiology at the Cleveland Clinics Foundation. He is a diplomate of the American Board of Neurology and Psychiatry and the American Board of Epilepsy and Clinical Neurophysiology. He is founding member and past President of the Lebanese League Against Epilepsy and a member of several scientific societies.
He participated in several clinical studies, gave more than 300 lectures regionally and internationally, and authored 70 peer reviewed publications and book chapters.<br><br>
Head of Scientific Committee Consultant Neurologist Sheikh Shakbout Medical City Professor, Khalifa University, Abu Dhabi, UAE
Consultant Neurologist
Sheikh Shakbout Medical City
Professor, Khalifa University
Abu Dhabi, UAE
Prof. Naji Riachi recently joined Sheikh Shakhbout Medical City as Consultant Neurologist and Khalifa University College of Medicine as Clerkship Director of Neurology and Assistant Dean for Clinical Affairs. Dr. Riachi was previously Tenured Full Professor and Chair of Department of Neurology at the Lebanese American University and Assistant Dean for Clinical Research at LAU School of Medicine in Beirut, Lebanon.
After a 4 years Post-Doctoral Research Fellowship at Case Western Reserve University in Cleveland, Ohio, he completed his Residency in Neurology at the University Hospitals of Cleveland, then a two-year Fellowship in Epilepsy and Clinical Neurophysiology at the Cleveland Clinics Foundation. He is a diplomate of the American Board of Neurology and Psychiatry and the American Board of Epilepsy and Clinical Neurophysiology. He is founding member and past President of the Lebanese League Against Epilepsy and a member of several scientific societies.
He participated in several clinical studies, gave more than 300 lectures regionally and internationally, and authored 70 peer reviewed publications and book chapters.<br><br>
Head of Scientific Committee Consultant Neurologist Sheikh Shakbout Medical City Professor, Khalifa University, Abu Dhabi, UAE
Completed Neurology residency program at Howard University Hospital in washington/ DC, USA in 2013
Became American board Certified Neurologist by the American Board of Psychiatric and Neurology in 2013
Completed Fellowship in Clinical neurophsyology/Epilepsy from Georgetown University Hospital in washington /DC, USA
Currently working as Neurology Consultant/ Clinical neurophysiologist / epilepsy at Tawam Hospital since 2018.
Consultant Neurologist & Epileptologist
Tawam Hospital
Al Ain, UAE
Completed Neurology residency program at Howard University Hospital in washington/ DC, USA in 2013
Became American board Certified Neurologist by the American Board of Psychiatric and Neurology in 2013
Completed Fellowship in Clinical neurophsyology/Epilepsy from Georgetown University Hospital in washington /DC, USA
Currently working as Neurology Consultant/ Clinical neurophysiologist / epilepsy at Tawam Hospital since 2018.
Dr. Roger Barranco Pons is a European board certified Interventional and NeuroInterventional radiologist with more than 15 years of experience in the management of neurovascular and vascular disease.
During his career he has completed his training with multiple experiences in different countries ( Spain,France, Italy, Germany, USA and Singapore)
He has worked as a Neurointerventional Radiologist at Bellvitge University Hospital. Universitat de Barcelona.(2012-2022) where he participated in multiple international neurovascular studies. For 5 years, he also was the former head for Interventional and Neurointerventional at Tarragona University Hospital, Spain.(2017-2022)
He has published in multiple peer reviewed journals been a speaker in multiple international meetings. He is also reviewer for multiple Neurovascular journals.
Currently he works in Tawam Hospital , United Arab Emirates. as an Interventiona Neuroradiologist.(2023)
Interventional Neuroradiologist
Tawam Hospital
Al Ain, UAE
Dr. Roger Barranco Pons is a European board certified Interventional and NeuroInterventional radiologist with more than 15 years of experience in the management of neurovascular and vascular disease.
During his career he has completed his training with multiple experiences in different countries ( Spain,France, Italy, Germany, USA and Singapore)
He has worked as a Neurointerventional Radiologist at Bellvitge University Hospital. Universitat de Barcelona.(2012-2022) where he participated in multiple international neurovascular studies. For 5 years, he also was the former head for Interventional and Neurointerventional at Tarragona University Hospital, Spain.(2017-2022)
He has published in multiple peer reviewed journals been a speaker in multiple international meetings. He is also reviewer for multiple Neurovascular journals.
Currently he works in Tawam Hospital , United Arab Emirates. as an Interventiona Neuroradiologist.(2023)
Dr Seby John is Consultant, Vascular Neurologist and Neurointerventional Surgeon at Cleveland Clinic Abu Dhabi.
He is currently Clinical Associate Professor of Neurology at Cleveland Clinic Lerner College of Medicine, USA and Khalifa University College of Medicine, UAE.
Dr John has extensive experience in the medical and interventional management of cerebrovascular diseases.
He is an active researcher and has been an investigator in numerous international cerebrovascular clinical trials.
He has to his credit, more than 75 peer-reviewed publications and book chapters in the field of stroke and neurointerventional surgery.
He is board of directors of MENA-SINO (Middle East North Africa Stroke and interventional Neurotherapies Organization) and the UAE Vascular Neurology Chair for Mission Thrombectomy 2020+.
He is an active reviewer for multiple journals, and is on the editorial board of Clinical Neurology and Neurosurgery.
Consultant, Vascular Neurology and
Neurointerventional Surgery
Cleveland Clinic Abu Dhabi, UAE
Dr Seby John is Consultant, Vascular Neurologist and Neurointerventional Surgeon at Cleveland Clinic Abu Dhabi.
He is currently Clinical Associate Professor of Neurology at Cleveland Clinic Lerner College of Medicine, USA and Khalifa University College of Medicine, UAE.
Dr John has extensive experience in the medical and interventional management of cerebrovascular diseases.
He is an active researcher and has been an investigator in numerous international cerebrovascular clinical trials.
He has to his credit, more than 75 peer-reviewed publications and book chapters in the field of stroke and neurointerventional surgery.
He is board of directors of MENA-SINO (Middle East North Africa Stroke and interventional Neurotherapies Organization) and the UAE Vascular Neurology Chair for Mission Thrombectomy 2020+.
He is an active reviewer for multiple journals, and is on the editorial board of Clinical Neurology and Neurosurgery.
Dr. Shivam Om Mittal received his medical degree from Datta Meghe University of Medical Sciences University in Wardha, India. He completed his neurology residency at University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio, USA. He did postdoctoral fellowship in botulinum toxin treatment at the prestigious Yale University, where he initiated several clinical studies and streamlined unique treatment options for movement disorders. To pursue his interest further in the field of clinical movement disorders he completed a fellowship in parkinson’s disease and movement disorders at the Renowned Mayo Clinic, Minnesota, USA.
Dr. Mittal lives in Abu Dhabi with his wife and two sons. He enjoys cycling, listening to music and spending time with his family.
Head of Parkinson’s Disease &
Movement Disorders Division
Consultant Neurologist
Cleveland Clinic Abu Dhabi, UAE
Dr. Shivam Om Mittal received his medical degree from Datta Meghe University of Medical Sciences University in Wardha, India. He completed his neurology residency at University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio, USA. He did postdoctoral fellowship in botulinum toxin treatment at the prestigious Yale University, where he initiated several clinical studies and streamlined unique treatment options for movement disorders. To pursue his interest further in the field of clinical movement disorders he completed a fellowship in parkinson’s disease and movement disorders at the Renowned Mayo Clinic, Minnesota, USA.
Dr. Mittal lives in Abu Dhabi with his wife and two sons. He enjoys cycling, listening to music and spending time with his family.
Dr Sunitha Mysore is deputy head and clinical lead for physiotherapy at Fatima College of Health Sciences Abu Dhabi since 2014. With over 25 years of significant experience in both clinical and higher education, Dr Sunitha have been teaching neurological physiotherapy and evidence-based practice to a wide range of healthcare students. Her study and work are in multi-cultural environments spanning in UK, Italy, Hong Kong, India and currently in the UAE. Dr Sunitha has bachelor and master’s degree in Physiotherapy and Post Graduate Certificate and Doctor of Education from the UK. As a clinical lead and curricular developer, she works with a wide range of stakeholders with the successful delivery of new initiatives and projects. She has designed and validated clinical assessment tools for physiotherapy students and conducted over 40 workshops in clinical education to the clinical partners. Her research work is in diverse areas of physiotherapy and education. Dr. Sunitha hold several professional memberships related to physiotherapy and education.
Deputy Head and Clinical Lead, Physiotherapy,
Fatima College of Health Sciences
Abu Dhabi, UAE
Dr. Sunitha Mysore is deputy head and clinical lead for physiotherapy at Fatima College of Health Sciences Abu Dhabi since 2014. With over 25 years of significant experience in both clinical and higher education, Dr Sunitha have been teaching neurological physiotherapy and evidence-based practice to a wide range of healthcare students. Her study and work are in multi-cultural environments spanning in UK, Italy, Hong Kong, India and currently in the UAE. Dr Sunitha has bachelor and master’s degree in Physiotherapy and Post Graduate Certificate and Doctor of Education from the UK. As a clinical lead and curricular developer, she works with a wide range of stakeholders with the successful delivery of new initiatives and projects. She has designed and validated clinical assessment tools for physiotherapy students and conducted over 40 workshops in clinical education to the clinical partners. Her research work is in diverse areas of physiotherapy and education. Dr. Sunitha hold several professional memberships related to physiotherapy and education.
Dr. Tanmoy Maiti has done his Neurosurgery residency in NIMHANS, India and done clinical fellowship in skull base and vascular (LSUHSC-S, USA), functional (Cleveland Clinic, Ohio, USA) and complex spine and deformity correction (Mayo Clinic, Arizona, USA). He is currently employed in Cleveland clinic Abu Dhabi. He has published more than 95 articles in peer-reviewed journals and authored several book chapters.
He is a section editor of World Neurosurgery and reviewer of several journals.
Associate Staff Physician, Neurosurgery
Neurological Institute
Cleveland Clinic Abu Dhabi, UAE
Dr. Tanmoy Maiti has done his Neurosurgery residency in NIMHANS, India and done clinical fellowship in skull base and vascular (LSUHSC-S, USA), functional (Cleveland Clinic, Ohio, USA) and complex spine and deformity correction (Mayo Clinic, Arizona, USA). He is currently employed in Cleveland clinic Abu Dhabi. He has published more than 95 articles in peer-reviewed journals and authored several book chapters.
He is a section editor of World Neurosurgery and reviewer of several journals.
Dr. Alsaadi is a Chief Medical officer and the Chair of the Neurology Department at the American Center of Psychiatry & Neurology (ACPN). He was trained in Epilepsy and Clinical Neurophysiology at the University of California San Francisco and was a research fellow in Epilepsy there. He is board-certified by the American Board of Psychiatry and Neurology and by the American Board of Clinical Neurophysiology and by the American Board of Neurology in Clinical Epilepsy.
Before joining ACPN, Dr. Alsaadi was the Chief of the Neurology Department at Sheikh Khalifa Medical City for 11 years. He previously held a position as an associate Professor of Neurology and the Director of the Adult Epilepsy Program and the Clinical Research Program at the University of California Davis. His research has focused on conducting drug study trials for new antiepileptic drugs for patients with epilepsy, quality of life in patients with epileptic and non-epileptic disorders, migraine headaches, multiple sclerosis, neuropsychiatric co-morbidities. Dr. Alsaadi has been honored with several prestigious awards for his work in the field of epilepsy. He has served on the Advisory Board of the Northern California Epilepsy Foundation and on the membership committee of the American Epilepsy Society.
He has previously served as the President of the Western Clinical Neurophysiology Society in the United Sates and as the Vice President of CEMA (Commission of the Eastern Mediterranean Affairs). He is currently the President of the Emirati League against epilepsy. He also serves at the Editorial Board for BMC Journal of Neurology and Journal of Neurosciences. He has authored and co-authored more than 65 papers and book chapters and has served as a peer-reviewer for more than 15 scientific journals.
Adjunct Professor of Neurology
Khalifa University, Chief Medical Officer
Chair of the Neurology Department
American Center for Psychiatry and Neurology (ACPN)
Abu Dhabi, UAE
Dr. Alsaadi is a Chief Medical officer and the Chair of the Neurology Department at the American Center of Psychiatry & Neurology (ACPN). He was trained in Epilepsy and Clinical Neurophysiology at the University of California San Francisco and was a research fellow in Epilepsy there. He is board-certified by the American Board of Psychiatry and Neurology and by the American Board of Clinical Neurophysiology and by the American Board of Neurology in Clinical Epilepsy.
Before joining ACPN, Dr. Alsaadi was the Chief of the Neurology Department at Sheikh Khalifa Medical City for 11 years. He previously held a position as an associate Professor of Neurology and the Director of the Adult Epilepsy Program and the Clinical Research Program at the University of California Davis. His research has focused on conducting drug study trials for new antiepileptic drugs for patients with epilepsy, quality of life in patients with epileptic and non-epileptic disorders, migraine headaches, multiple sclerosis, neuropsychiatric co-morbidities. Dr. Alsaadi has been honored with several prestigious awards for his work in the field of epilepsy. He has served on the Advisory Board of the Northern California Epilepsy Foundation and on the membership committee of the American Epilepsy Society.
He has previously served as the President of the Western Clinical Neurophysiology Society in the United Sates and as the Vice President of CEMA (Commission of the Eastern Mediterranean Affairs). He is currently the President of the Emirati League against epilepsy. He also serves at the Editorial Board for BMC Journal of Neurology and Journal of Neurosciences. He has authored and co-authored more than 65 papers and book chapters and has served as a peer-reviewer for more than 15 scientific journals.
Mansoor Musthafa Varamangalath, is a Senior Speech Language Pathologist currently practising in Tawam Hospital, in acute care. Mansoor received his Master Degree in Audiology and Speech Language Pathology from Kerala University of Health sciences, Kerala, India. Mansoor has over 10 years of experience in various setting including, outpatients, long term care and acute care. Mansoor specializes in inpatient acute care setting, evaluating and treating acute adult patients with speech, language, cognitive, and swallow impairments and providing intervention in these specific areas. His main area of interest is in patients with neurological disorders specifically stroke assessment and rehabilitation. He provides training to nurses in Swallow screening for stroke patients and is involved in developing stroke educational material. He is an active member of the Stroke Care Team and multidisciplinary rehabilitation team. He is skilled in video fluoroscopic studies (VFSS) and holds a certification as registered MBSImP clinician and trained in the Montreal Cognitive Assessment (MoCA). He is a speaker at various local and international conferences and is involved in various educational and training programs in the facility.
Speech and Language Therapy
Tawam Hospital, Al Ain, UAE
Mansoor Musthafa Varamangalath, is a Senior Speech Language Pathologist currently practising in Tawam Hospital, in acute care. Mansoor received his Master Degree in Audiology and Speech Language Pathology from Kerala University of Health sciences, Kerala, India. Mansoor has over 10 years of experience in various setting including, outpatients, long term care and acute care. Mansoor specializes in inpatient acute care setting, evaluating and treating acute adult patients with speech, language, cognitive, and swallow impairments and providing intervention in these specific areas. His main area of interest is in patients with neurological disorders specifically stroke assessment and rehabilitation. He provides training to nurses in Swallow screening for stroke patients and is involved in developing stroke educational material. He is an active member of the Stroke Care Team and multidisciplinary rehabilitation team. He is skilled in video fluoroscopic studies (VFSS) and holds a certification as registered MBSImP clinician and trained in the Montreal Cognitive Assessment (MoCA). He is a speaker at various local and international conferences and is involved in various educational and training programs in the facility.
I am qualified OT with international experience in the profession and with specialist interest in paediatric and Neurology services. I have vast experience across various sectors in education, health care and community settings across the United Arab Emirates, Saudi Arabia, South Africa and Jordan. I hold professional registrations with organizations in Jordan and South African. I am a trainer in Neuro-Developmental Therapy (Bobath qualified).
I have presented my work at various conferences across the world, such as South Africa, England, Syria, Yemen, Oman, Jordan and UAE. As a member of SEHA OT Advisory group, I participated in formulating OT clinical guidelines, developing and reviewing professional policies and working on KPI to improve the OT services across SEHA facilities. I also represent OTs and Tawam team in SEHA educational Committee
Occupational Therapy
Tawam Hospital, Al Ain, UAE
I am qualified OT with international experience in the profession and with specialist interest in paediatric and Neurology services. I have vast experience across various sectors in education, health care and community settings across the United Arab Emirates, Saudi Arabia, South Africa and Jordan. I hold professional registrations with organizations in Jordan and South African. I am a trainer in Neuro-Developmental Therapy (Bobath qualified).
I have presented my work at various conferences across the world, such as South Africa, England, Syria, Yemen, Oman, Jordan and UAE. As a member of SEHA OT Advisory group, I participated in formulating OT clinical guidelines, developing and reviewing professional policies and working on KPI to improve the OT services across SEHA facilities. I also represent OTs and Tawam team in SEHA educational Committee
I am Meera Mohideen an accomplished Lead Physiotherapist with over 20 years of experience in the field of Neuro-Musculoskeletal Physiotherapy. I myself consider as a Successful therapist in my profession. I have the ability to transform a patient’s life from a plinth to performance state. More than my role as a physiotherapist, I am effective at persuading and influencing high ranking individuals. I earned my Master’s degree in musculoskeletal physiotherapy back in 2007 and spent about 7 years at NMC Specialty Hospital, Dubai but my goal was to establish my professional life in an Acute & In-Patient Care which forced me to get in to Tawam Hospital.
In Particular, I am a passionate physiotherapist in treating people with Neuro-Musculoskeletal Disorders. My focusses on Neuro rehabilitation – Early Mobility, Improve Patient’s quality of Life, return the individuals near to normal life. I am also an expertise in Vestibular Rehabilitation. I also contributed my valuable knowledge as a part of MDT in obtaining Stroke Excellence Centre at Tawam acknowledged by American Heart Association.
Physiotherapist
Tawam Hospital, Al Ain, UAE
I am Meera Mohideen an accomplished Lead Physiotherapist with over 20 years of experience in the field of Neuro-Musculoskeletal Physiotherapy. I myself consider as a Successful therapist in my profession. I have the ability to transform a patient’s life from a plinth to performance state. More than my role as a physiotherapist, I am effective at persuading and influencing high ranking individuals. I earned my Master’s degree in musculoskeletal physiotherapy back in 2007 and spent about 7 years at NMC Specialty Hospital, Dubai but my goal was to establish my professional life in an Acute & In-Patient Care which forced me to get in to Tawam Hospital.
In Particular, I am a passionate physiotherapist in treating people with Neuro-Musculoskeletal Disorders. My focusses on Neuro rehabilitation – Early Mobility, Improve Patient’s quality of Life, return the individuals near to normal life. I am also an expertise in Vestibular Rehabilitation. I also contributed my valuable knowledge as a part of MDT in obtaining Stroke Excellence Centre at Tawam acknowledged by American Heart Association.
Consultant Neurologist
Sheikh Shakbout Medical City
Abu Dhabi, UAE
Consultant Neurologist
Sheikh Shakbout Medical City
Abu Dhabi, UAE
Consultant Neurologist
Sheikh Shakbout Medical City
Abu Dhabi, UAE